Abstract
Suppression or overexpression of transmembrane proteins of the Wnt family and receptor tyrosine kinases (ROR1 and ROR2) is implicated in the causation of cancer. The objective of this study was to determine the expression of ROR2 in patients with giant cell tumor of bone (GCT) by quantitative PCR (qPCR). In this case‒control study, samples of tumor tissue (patients) and bone from the tumor-free margin (controls) were subjected to qPCR in patients who underwent definitive treatment. The GCTs were classified per radiologic classification and histologic grading. Eleven cases and controls, consisting of six men and five women with a mean age of 33.18 ± 12.35 (20–50) years, were included over the study period of 2 years. The median duration since diagnosis was 12 (IQR 9) months. There was a 2.51-fold change (upregulation of ROR2 expression) in cases compared with controls, which was significant (0.00). There was an increase in the expression of ROR2 with tumor grade. However, these differences were not significant (Campanacci (P 0.05 cases and 0.84 controls), Jaffe (P 0.07 cases and 0.44 controls), or Enneking (0.07 cases and 0.44 controls)). Treatment with bisphosphonates (P = 0.17) or denosumab (P = 0.75) had no significant effect on ROR2 expression. Patients with GCT exhibit more than twofold upregulation of ROR2 expression, confirming its role in causing osteoclast-mediated bone destruction. Therefore, ROR2 may be a target for drug development in the treatment of GCT.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author, [SKN], upon reasonable request.
References
Lu BJ, Wang YQ, Wei XJ, Rong LQ, Wei D, Yan CM et al (2012) Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol Med Rep 5:1033–1036
Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H et al (2009) Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 100:1227–1233
Maeda K, Kobayashi Y, Udagawa N, Uehara S, Ishihara A, Mizoguchi T et al (2012) Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med 18:405–412
Thorup AS, Strachan D, Caxaria S, Poulet B, Thomas BL, Eldridge SE et al (2020) ROR2 blockade as a therapy for osteoarthritis. Sci Transl Med. 12:eaax3063
Jiang Z, Jiang C, Yu C, Fang J (2017) MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2. Tumor Biol 39:1010428317705751
Funding
This study was funded by Jawaharlal Institute of Postgraduate medical education and research Pondicherry India under Intramural funding program of the institute.
Author information
Authors and Affiliations
Contributions
Dr. Sandeep Kumar Nema contributed to conceptualization, funding acquisition, methodology and supervision, manuscript preparation, and review. Dr. Shiva S. contributed to formal analysis, investigation, project administration, resources, and software. Dr. Shyam Kumar Tripathi contributed to formal analysis, resources, and manuscript preparation. Dr. Kirubakaran Saraswathy P. contributed to validation and manuscript review.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
S., S., Nema, S.K., Tripathi, S.K. et al. Twofold Expression of Receptor Tyrosine Kinase 2 (ROR2) in Giant Cell Tumors of Bone: Outcome of a Case‒Control Study. Indian J Surg Oncol (2024). https://doi.org/10.1007/s13193-024-01965-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13193-024-01965-3